YounHaKimMD

Anesthesiology • Placentia, CA

Physician

Join to view full profile

Are you Dr. Kim?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
1301 N Rose Dr
Placentia, CA 92870
Phone+1 714-993-2000

Summary

Dr. Youn Kim, MD is a board certified anesthesiologist in Placentia, California. He is currently licensed to practice medicine in California, Pennsylvania, and Massachusetts. He is affiliated with Placentia-Linda Hospital.

Education & Training

New York Medical College at Metropolitan HospitalResidency, Anesthesiology, 1982 - 1984
Montefiore - Mount Vernon HospitalInternship, Transitional Year, 1981 - 1982
Korea University College of MedicineClass of 1976

Certifications & Licensure

CA State Medical License 1989 - 2021
MA State Medical License 1982 - 1999
PA State Medical License 1984 - 1990
American Board of Anesthesiology Anesthesiology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2004-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013

Clinical Trials

Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma Start of enrollment: 2001 Apr 01
Completed
Phase 1
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma Start of enrollment: 2007 Jan 01
Terminated
Phase 2
Forodesine in the Treatment of Cutaneous T-Cell Lymphoma Start of enrollment: 2007 Jul 01
Completed
Phase 2
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma Start of enrollment: 2009 May 01
Completed
Phase 2
Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides Start of enrollment: 2010 Dec 01
Terminated
Phase 1, Phase 2
Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level Start of enrollment: 2011 May 01
Completed
Phase 2
Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting Start of enrollment: 2012 Jan 01
Completed
Phase 3
Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL Start of enrollment: 2012 Nov 01
Completed
Phase 3
NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) Start of enrollment: 2015 Dec 01
Unknown status
Phase 2
Join now to see all

Publications & Presentations

PubMed

Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab.
Francine Foss, Youn H Kim, Julia Scarisbrick, Oleg Akilov, Robert Ristuccia
The Journal of Dermatological Treatment. 2025-12-01
Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma.
Steven M Horwitz, Tatyana A Feldman, Jing Christine Ye, Michael S Khodadoust, Javier Munoz
Leukemia & Lymphoma. 2025-02-08
2 citations
A modified induced membrane 2-stage technique using a thoracodorsal artery perforator free flap followed by vascularized or non-vascularized free fibular transfer for ...
Lan Sook Chang, Dae Kwan Kim, Kyu Tae Hwang, Youn Hwan Kim, Sang Wha Kim
Injury. 2023-10-01